Health Affairs December 1, 2023
This year, the pharmaceutical market continues to be in the news. The Senate has taken up legislation placing new requirements on pharmacy benefit managers (PBMs), while the summer saw yet another drug shortage crisis, this time with generic cancer therapies, including Cisplatin. In the frantic search for understanding why these shortages have occurred, many policy makers asked questions about the role of hospital group purchasing organizations (GPOs) in the generic drug market.
It seems almost prescient that Lawton Robert Burns has written a volume about these two types of organizations and has combined his analysis of both organizational types into a single narrative. In The Healthcare Value Chain: Demystifying the Role of GPOs and PBMs, Burns has used his perch...
Today's Sponsors
Today's Sponsor